Clinical updates, including trial initiations, enrollment status and data readouts and publications: Agenus, Aileron, Airway, Alzecure, Amgen, Ose, Quantum.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbott.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Amneal, Astrazeneca, Edesa, Everest, Hutchmed, Inmune, Ose, Pardes, Ryvu, Servier, Turn.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Diadem, Hyperfine.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Affibody, Arcutis, Ascletis, Bluewillow, Bridgebio, Brii, Clarity, Cortexyme, Cytodyn, Emergent, Fibrogen, Flexion, FSD, IBT, Inmagene, Janssen, Lianbio, Lipocine, Merck, Novavax, Noxopharm, Rafael, Senhwa, Xrad.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adjuvance, Awakn, Cartesian, Eom, Meiji, Nouscom, Novartis, Oramed, Oncotelic, Regeneron, Reistone, Sorrento, Theravance, Timber.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Amerimmune, Astrazeneca, Biophytis, Coherus, Exevir, Histogen, Innocare, Innovent, Junshi, Kyowa Kirin, Mei, Nrx, Senhwa, Telix, Tiziana Life Sciences, Transcenta, Zhaoke Ophthalmology.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Sight Sciences.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Bavarian Nordic, Foghorn, Hepagene, Kezar, Lexicon, Orphazyme Plus, Puretech, Sen-Jam.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Masimo, Oncimmune, Strata Oncology.